Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Delirium Prevention in Elderly Hospitalized Patients
NCT02282241Phase 4Withdrawn
- Sponsor
- University of British Columbia
- Start
- Feb 2016
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of melatonin in delirium, sponsored by University of British Columbia. Planned start Feb 2016; status: withdrawn.
02
Drugs
melatonin
03
Conditions
delirium
Beyond the preview
Go deeper on NCT02282241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02282241.